Chevy Chase Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.2M Sell
2,789,125
-50,786
-2% -$1.33M 0.17% 107
2026
Q1
$79.7M Sell
2,839,911
-81,713
-3% -$2.18M 0.23% 87
2025
Q4
$72.7M Sell
2,921,624
-19,919
-0.7% -$502K 0.2% 103
2025
Q3
$75M Sell
2,941,543
-106,786
-4% -$2.64M 0.21% 99
2025
Q2
$73.9M Buy
3,048,329
+26,913
+0.9% +$628K 0.21% 99
2025
Q1
$76.6M Sell
3,021,416
-6,984
-0.2% -$183K 0.24% 87
2024
Q4
$80.3M Sell
3,028,400
-72,802
-2% -$1.97M 0.24% 81
2024
Q3
$89.7M Sell
3,101,202
-56,348
-2% -$1.64M 0.28% 73
2024
Q2
$88.3M Sell
3,157,550
-36,104
-1% -$994K 0.28% 70
2024
Q1
$88.6M Sell
3,193,654
-33,301
-1% -$924K 0.29% 70
2023
Q4
$92.9M Sell
3,226,955
-20,910
-0.6% -$632K 0.33% 63
2023
Q3
$108M Sell
3,247,865
-75,422
-2% -$2.67M 0.43% 49
2023
Q2
$122M Sell
3,323,287
-21,896
-0.7% -$852K 0.46% 44
2023
Q1
$136M Buy
3,345,183
+25,601
+0.8% +$1.11M 0.54% 37
2022
Q4
$170M Sell
3,319,582
-200,420
-6% -$9.61M 0.72% 27
2022
Q3
$154M Buy
3,520,002
+40,933
+1% +$1.99M 0.66% 30
2022
Q2
$182M Buy
3,479,069
+12,950
+0.4% +$660K 0.75% 21
2022
Q1
$179M Buy
3,466,119
+8,620
+0.2% +$447K 0.62% 27
2021
Q4
$204M Sell
3,457,499
-80,775
-2% -$4M 0.66% 24
2021
Q3
$152M Sell
3,538,274
-124,912
-3% -$5.53M 0.53% 36
2021
Q2
$143M Sell
3,663,186
-174,583
-5% -$6.79M 0.49% 38
2021
Q1
$139M Sell
3,837,769
-311,002
-7% -$11M 0.5% 38
2020
Q4
$153M Sell
4,148,771
-356,436
-8% -$13.1M 0.54% 36
2020
Q3
$157M Sell
4,505,207
-372,346
-8% -$13.1M 0.62% 30
2020
Q2
$151M Sell
4,877,553
-245,192
-5% -$8.33M 0.61% 31
2020
Q1
$159M Buy
5,122,745
+88,630
+2% +$3.02M 0.74% 23
2019
Q4
$187M Sell
5,034,115
-14,235
-0.3% -$507K 0.71% 28
2019
Q3
$172M Sell
5,048,350
-22,384
-0.4% -$814K 0.71% 28
2019
Q2
$208M Sell
5,070,734
-8,756
-0.2% -$348K 0.86% 20
2019
Q1
$196M Sell
5,079,490
-133,858
-3% -$5.36M 0.81% 22
2018
Q4
$216M Sell
5,213,348
-185,867
-3% -$7.72M 1.05% 14
2018
Q3
$226M Sell
5,399,215
-109,695
-2% -$4.22M 0.94% 17
2018
Q2
$190M Sell
5,508,910
-103,893
-2% -$3.55M 0.82% 23
2018
Q1
$189M Sell
5,612,803
-136,474
-2% -$4.69M 0.84% 20
2017
Q4
$198M Sell
5,749,277
-44,444
-0.8% -$1.52M 0.85% 22
2017
Q3
$196M Buy
5,793,721
+68,189
+1% +$2.19M 0.89% 21
2017
Q2
$182M Buy
5,725,532
+3,672
+0.1% +$116K 0.87% 23
2017
Q1
$186M Buy
5,721,860
+48,869
+0.9% +$1.54M 0.91% 20
2016
Q4
$175M Sell
5,672,991
-8,542
-0.2% -$261K 0.93% 20
2016
Q3
$183M Sell
5,681,533
-105,504
-2% -$3.53M 1% 15
2016
Q2
$193M Buy
5,787,037
+74,003
+1% +$2.36M 1.08% 15
2016
Q1
$161M Buy
5,713,034
+5,063
+0.1% +$145K 0.92% 18
2015
Q4
$175M Buy
5,707,971
+29,707
+0.5% +$935K 1.03% 16
2015
Q3
$169M Buy
5,678,264
+178,421
+3% +$5.72M 1.06% 14
2015
Q2
$175M Buy
5,499,843
+83,424
+2% +$2.72M 1.05% 12
2015
Q1
$179M Buy
5,416,419
+39,609
+0.7% +$1.26M 1.08% 11
2014
Q4
$159M Sell
5,376,810
-84,126
-2% -$2.41M 0.99% 13
2014
Q3
$153M Buy
5,460,936
+356,708
+7% +$10M 0.99% 14
2014
Q2
$144M Sell
5,104,228
-107,959
-2% -$3.08M 1% 14
2014
Q1
$159M Sell
5,212,187
-80,011
-2% -$2.39M 1.14% 12
2013
Q4
$154M Sell
5,292,198
-44,788
-0.8% -$1.3M 1.12% 13
2013
Q3
$145M Buy
5,336,986
+55,918
+1% +$1.52M 1.19% 12
2013
Q2
$140M Buy
+5,281,068
New +$146M 1.23% 14

Other funds holding PFE

Chevy Chase Trust's PFE Position: Q2 2026 in Review

Chevy Chase Trust reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $1.33M and leaving 2,789,125 shares worth $67.2M. The position accounts for 0.17% of the portfolio, ranked #107.

Chevy Chase Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $226M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chevy Chase Trust held 2,789,125 shares of Pfizer worth $67.2M as of Q2 2026.
  • Chevy Chase Trust sold 50,786 Pfizer shares in Q2 2026, an estimated $1.33M.
  • Pfizer made up 0.17% of Chevy Chase Trust's portfolio in Q2 2026, its #107 holding.
  • Chevy Chase Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Chevy Chase Trust's Pfizer position peaked at $226M in Q3 2018.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.